Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ: GLMD · IEX Real-Time Price · USD

0.285

-0.003 (-0.94%)

At close: Jul 2, 2024, 3:55 PM

0.303

+0.018 (6.20%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Galmed Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-6.91	-17.87	-32.47	-28.77	-20.46	Upgrade
Depreciation & Amortization	0.03	0.04	0.04	0.04	0.04	Upgrade
Share-Based Compensation	0.89	1.3	1.89	2.07	2.23	Upgrade
Other Operating Activities	-0.15	-1.97	-2.35	0.38	3.26	Upgrade
Operating Cash Flow	-6.14	-18.5	-32.89	-26.29	-14.94	Upgrade
Capital Expenditures	0	-0	-0.01	-0.04	-0.01	Upgrade
Acquisitions	-1.5	0	0	0	0	Upgrade
Change in Investments	2.3	17.57	11.47	16.58	6.69	Upgrade
Other Investing Activities	-	-	-0	-	-	Upgrade
Investing Cash Flow	0.8	17.56	11.46	16.54	6.68	Upgrade
Share Issuance / Repurchase	6.19	0.07	17.37	0.77	0.14	Upgrade
Financing Cash Flow	6.19	0.07	17.37	0.77	0.14	Upgrade
Net Cash Flow	0.85	-0.87	-4.06	-8.98	-8.12	Upgrade
Free Cash Flow	-6.14	-18.51	-32.9	-26.33	-14.95	Upgrade
Free Cash Flow Per Share	-2.22	-11.04	-20.07	-18.56	-10.62	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).